TherapeuticsMD, Inc. (TXMD)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-01-21

Key Insights

  • TherapeuticsMD, Inc. has appointed a new independent registered public accounting firm, Carr, Riggs & Ingram, L.L.C., after its previous auditor, Berkowitz Pollack Brant Advisors + CPAs, ceased serving as the company's auditor due to a transaction.
  • The company's previous auditor's reports on the financial statements for fiscal years 2023 and 2024 included an explanatory paragraph regarding the company's ability to continue as a going concern, which may indicate ongoing financial challenges.
  • There were no disagreements between the company and its previous auditor, and the company did not consult the new auditor on any accounting, auditing, or financial reporting issues prior to their appointment.
Filing tone (AI): Neutral
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new TherapeuticsMD, Inc. filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.